Aprea Therapeutics, Inc. (APRE) vs KALA BIO, Inc. (KALA)
Aprea Therapeutics, Inc. and KALA BIO, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and KALA BIO, Inc. are of similar size ($10.7M and $9.8M). KALA BIO, Inc. grew revenue faster over the last twelve months: −50.5% against −81.0%. Across the 13 metrics below, Aprea Therapeutics, Inc. leads on 8 and KALA BIO, Inc. on 5.
Valuation
Profitability
| Metric | APRE | KALA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (47.44%) | (345.32%) | (57.72%) |
| Return on assets | (41.30%) | (43.23%) | (49.22%) |
| Return on invested capital | 0.00% | (722.69%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack